ArticleYonsei medical journal2020

Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.

Hyung Joon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.